PSMA-targeted surgery may benefit PCa patients with PSMA-TB because of a more accurate pathological diagnosis by PSMA-RGS or PSMA-FGS for a more accurate resection of all prostatic and metastatic lesions. The gene discussed is FOLH1; the disease is posterior cortical atrophy.